No minimums. No exclusivity. No cost to the university at any stage before a company is formed.
The university's tech-transfer office refers disclosures at its sole discretion. We accept or decline in ours.
A written commercial evaluation — market sizing, freedom-to-operate, regulatory pathway — within 30 days, at no cost.
For selected technologies: a company is formed, operators are recruited, and a license is negotiated on terms the university approves.
Studio and venture-partner capital, non-dilutive SBIR/STTR grants, and follow-on investor rounds carry the company forward.
A managed pipeline for faculty and student disclosures, with a written response inside 10 business days. Nothing sits in a drawer.
Market sizing, freedom-to-operate analysis, and regulatory pathway for every referred disclosure, delivered inside 30 days.
Patent-strategy support and license terms benchmarked to the R1 standard — the same bands used by Harvard, MIT, and Stanford.
The studio forms each company, writes the business plan, and recruits experienced operators to run it day to day.
First checks from the studio and our venture partners, extended by non-dilutive SBIR/STTR grants.
Annual reporting to the university — a pipeline the administration can see, track, and govern.
Nothing here is a discount version of technology transfer — these are the published bands the top research universities already use.
2–5% of net sales — the same band the R1s use — for the life of every licensed product, plus milestone payments.
A 3–10% founder stake in every company formed on the university's IP — at or above R1 norms.
15–30% of sublicense proceeds — standard top-tier terms.
Zero. The studio funds evaluation and company formation and earns only when companies succeed.
JUST BUILDS